Jacobs Levy Equity Management Inc. Purchases Shares of 21,784 Ardent Health Partners, LLC (NYSE:ARDT)

Jacobs Levy Equity Management Inc. purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 21,784 shares of the company’s stock, valued at approximately $372,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. US Bancorp DE bought a new position in Ardent Health Partners during the fourth quarter valued at approximately $31,000. R Squared Ltd bought a new position in Ardent Health Partners during the fourth quarter valued at approximately $37,000. New York State Common Retirement Fund bought a new position in Ardent Health Partners during the fourth quarter valued at approximately $48,000. Deutsche Bank AG grew its position in Ardent Health Partners by 1,251.9% during the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock valued at $49,000 after acquiring an additional 2,654 shares during the last quarter. Finally, Wells Fargo & Company MN grew its holdings in shares of Ardent Health Partners by 52.6% in the fourth quarter. Wells Fargo & Company MN now owns 8,704 shares of the company’s stock worth $149,000 after purchasing an additional 3,002 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ARDT. Mizuho lowered their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. Stephens reissued an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Royal Bank of Canada reissued an “outperform” rating and issued a $21.00 price target on shares of Ardent Health Partners in a report on Thursday. Finally, Guggenheim raised their price target on shares of Ardent Health Partners from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $20.75.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $15.40 on Friday. The stock has a market cap of $2.20 billion and a P/E ratio of 9.45. The firm’s fifty day simple moving average is $13.13 and its 200 day simple moving average is $14.83. Ardent Health Partners, LLC has a twelve month low of $11.31 and a twelve month high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. As a group, research analysts predict that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.